Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases

Int J Mol Sci. 2022 Sep 7;23(18):10275. doi: 10.3390/ijms231810275.

Authors

Satoshi Saito¹, Kenjiro Ono², Masashi Tanaka³

Affiliations

¹ Department of Neurology, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Osaka 564-8565, Japan.
² Department of Neurology, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
³ Department of Physical Therapy, Health Science University, 7187 Kodachi, Fujikawaguchiko-machi, Minamitsuru-gun, Yamanashi 401-0380, Japan.

Abstract

The rate of dementia continues to increase worldwide; however, there currently exist no therapeutic strategies for this condition [...].

Publication types

Editorial

MeSH terms

Alzheimer Disease*
Amyloid beta-Peptides
Humans
Neurodegenerative Diseases*

Substances

Amyloid beta-Peptides

Grants and funding

This research received no external funding.